Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of the Interleukin-6 Receptor Antagonist Tocilizumab in Non-ST Elevation Myocardial Infarction - a Randomized, Double Blind, Placebo Controlled Study.

NCT01491074 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT01491074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01491074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of the Interleukin-6 Receptor Antagonist Tocilizumab in Non-ST Elevation Myocardial Infarction - a Randomized, Double Blind, Placebo Controlled Study.
Lead sponsor
Oslo University Hospital
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2011
Completion date
April 30, 2014
Enrollment
120 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

non-st elevation myocardial infarction